×

Celgene CEO: FDA places 'FUSION' trials on hold in 'cautionary approach'

8:50 AM ET Thu, 7 Sept 2017

We're stopping now to understand what's happening, says Mark Alles, Celgene CEO, talking about the company's latest cancer drug trials.